HOME > R&D > Autologous Therapy
Under construction please wait.
Develop and provide autologous anti-cancer therapy by using BionanosomeⓇ derived from cancer patient immune cell
Solve immunogenicity issues of the therapy
Service will begin with autologous BionanosomeⓇ + Doxorubicin in major domestic hospitals
Service will be expanded overseas by partnering and/or our affiliated companies